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Abstract
Background: Overviews of systematic reviews are an increasingly popular method of evidence synthesis; there is a
lack of clear guidance for completing overviews and a number of methodological challenges. At the UK Cochrane
Symposium 2016, methodological challenges of five overviews were explored. Using data from these five
overviews, practical implications to support methodological decision making of authors writing protocols for future
overviews are proposed.
Methods: Methods, and their justification, from the five exemplar overviews were tabulated and compared with
areas of debate identified within current literature. Key methodological challenges and implications for
development of overview protocols were generated and synthesised into a list, discussed and refined until there
was consensus.
Results: Methodological features of three Cochrane overviews, one overview of diagnostic test accuracy and one
mixed methods overview have been summarised. Methods of selection of reviews and data extraction were similar.
Either the AMSTAR or ROBIS tool was used to assess quality of included reviews. The GRADE approach was most
commonly used to assess quality of evidence within the reviews.
Eight key methodological challenges were identified from the exemplar overviews. There was good agreement
between our findings and emerging areas of debate within a recent published synthesis. Implications for
development of protocols for future overviews were identified.
Conclusions: Overviews are a relatively new methodological innovation, and there are currently substantial
variations in the methodological approaches used within different overviews. There are considerable
methodological challenges for which optimal solutions are not necessarily yet known. Lessons learnt from five
exemplar overviews highlight a number of methodological decisions which may be beneficial to consider during
the development of an overview protocol.
Keywords: Challenges, Methods, Overviews, Quality assessment, Synthesis
Background
Overviews of systematic reviews are an increasingly
popular method of evidence synthesis [1, 2], and there
are a growing number of resources, including guidelines,
recommendations, descriptions and systematic reviews,
relating to overview methods [2–6]. While there are
some areas of agreement in relation to optimal overview
methods, particularly in the early stages of overview
completion [5], there remains considerable uncertainty
around some key areas of methodology [3, 5, 7, 8] and a
need for clearer standards and reporting guidance, sup-
ported by research evidence, to enhance methodological
quality of overviews [1–3, 5, 6].
At the UK Cochrane Symposium in 2016, a workshop
focusing on the methods and challenges associated with
overviews included presentations relating to five selected
ongoing or recently completed overviews [9]. These
were selected in order to highlight practical variations in
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the methods adopted within different overviews and to
provide tangible examples of the decisions and chal-
lenges associated with the completion of an overview.
During and following this workshop, we explored prac-
tical issues associated with planning and preparing these
exemplar overviews, discussed the impact of methodo-
logical decisions and reached consensus on key meth-
odological challenges and potential implications for
future overview authors.
Subsequent to our author group reaching consensus,
Ballard [3] published the results of a scoping review of
methodological guidance for overviews. This synthesis
identified areas where there was consensus relating to
overview methods and highlighted five key areas where
there was debate or uncertainty including “(i) overlap-
ping systematic reviews, (ii) the scope of systematic re-
views, (iii) evaluating the quality and reporting of
included research, (iv) updating included systematic re-
views, and (v) synthesizing and reporting the results of
included systematic reviews” [3]. Since the search period
of this comprehensive synthesis, a number of further pa-
pers relevant to overview methods have been published
adding to the discussion and debate around key areas of
uncertainty. These include summaries of guidance relat-
ing to overview methods [5], descriptions and debate re-
lating to the use of GRADE [10–12] and AMSTAR [13],
the development of a new tool to assess risk of bias
(ROBIS [14]), and protocols for ongoing work in this
field [15, 16]. The specific debate around methodological
challenges presented by Ballard [3], and these subse-
quent related publications, afforded us a timely oppor-
tunity to compare the results of our independent
consensus arising from our five exemplar overviews and
to explore the practical implications of the current un-
certainties around overview methods for authors plan-
ning protocols for new overviews.
Our aim is therefore to use five exemplar overviews:
(i) To provide practical examples of methodological
approaches to the planning and preparing of
overviews and discuss the impact of methodological
decisions
(ii) To explore methodological challenges reported by
overview authors and compare these with areas of
debate identified within current literature
(iii) To discuss practical implications which may support
methodological decision making during development
of protocols for future overviews
Methods
Methodological features of exemplar overviews
Methods of the five exemplar overviews were tabulated,
relating to all key stages in the process of completing an
overview. Justification for the selection and use of the
methods at each stage were provided by the overview
authors, based on the presentations provided at the
Cochrane Workshop and supplemented by discussion
(authors representing all five exemplar overviews are in-
cluded as authors on this paper). Points of agreement
and dissonance were highlighted and discussed. The key
methodological challenges identified by each overview
author were discussed at the workshop and synthesised
into a list, with similar challenges merged. A description
of each challenge, and the solutions (if any) imple-
mented within individual overviews, was developed
through discussion. A list of potential implications for
future overview authors, arising from the practical expe-
riences within these exemplar overviews, was developed
iteratively. This initially comprised a list of key methodo-
logical decisions made by the overview authors arising
from the tabulated descriptions of methods and meth-
odological challenges; this was circulated amongst the
overview authors who added to, and refined until con-
sensus was reached on the final list.
Key challenges within exemplar overviews and
complementarity with published literature on overview
methods
The key methodological challenges identified within
each of the exemplar overviews were systematically com-
pared and contrasted with the recognised areas of debate
[3], which were published after consensus had been
reached on the methodological challenges identified
within our exemplar overviews. Each of the methodo-
logical challenges from our exemplar overviews were
tabulated, and overview authors considered levels of
complementarity [17, 18] between the recognised areas
of debate and the methodological challenges identified
from our exemplar overviews, applying categories of
“agreement” (the methodological challenges identified
within the exemplar overviews is in agreement with the
findings of Ballard [3]), “dissonance” (the methodological
challenges identified within the exemplar overviews dif-
fers from, or conflicts with, the findings of Ballard [3])
or “silence” (the methodological challenges identified
within the exemplar overviews were not addressed
within the findings of Ballard [3, 17, 18]. One author
applied the initial categorisation, which were then
appraised by the other authors and any areas of dis-
agreement highlighted. Disagreements were discussed
between all authors until consensus was reached, the
findings of other recent publications were considered,
and any changes from the original categorisation noted.
Implications for development of protocols for future
overviews
Finally, based on the presentations on the methods of
the exemplar overviews from the Cochrane Symposium
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which all provided a chronological description of the
overview process and the synthesis of methodological
features, common features and differences between our
exemplar overviews were identified and agreed. Consid-
ering these features and differences alongside the per-
ceived methodological challenges and complementarity
with published literature, overview authors then debated
and agreed key implications for the development of pro-
tocols for future overviews.
Results
Methodological features of exemplar overviews
Table 1 summarises the key methodological features of
the five exemplar overviews. Three of the overviews are
Cochrane overviews [19–21], one is an overview of re-
views of diagnostic test accuracy (DTA) [22], and one a
mixed method overview carried out by the EPPI centre
[23]. Two of the Cochrane overviews are produced by the
same research team (AP is an author on [19] and [21]),
while the remaining three are each produced by distinct
author groups. Detailed protocols describing the planned
methods were agreed and made available a priori for all
five of the overviews; two of the overviews are now
complete and published [19, 23], while three are in the
final stages of completion and write-up [20–22]. Justifica-
tion for the selection and use of the methods as described
in the protocol and used at each stage of the overview
process are provided in Table 1. Characteristics of the in-
cluded reviews and any data relating to the results of
meta-analyses which were extracted and reported within
the systematic reviews are summarised in Table 2.
Key challenges within exemplar overviews and
complementarity with published literature on overview
methods
Discussion between overview authors led to agreement
that there were a total of eight key methodological chal-
lenges encountered across all the exemplar overviews.
These were the following:
 Overlap between reviews (studies appearing in more
than one review)
 Reviews are out of date
 Definition of “systematic review”
 Assessment of methodological quality of reviews
 Quality of reporting within reviews
 Applying GRADE
 Potential for publication bias
 Summarising key findings in brief accessible format,
suitable for informing decision making
The judgement of complementarity between these
identified methodological challenges and the areas of
debate identified within current literature are sum-
marised in Table 3 and below.
Complementarity with published literature
 Agreement: seven of our identified key
methodological challenges were in agreement with
the issues raised by Ballard [3]; although, some
additional specific points (categorised as areas of
dissonance) were raised by our exemplar overviews
in relation to three of the issues (see Table 3 for
details)
 Silence:
o Methodological challenge highlighted by our
overviews, but not raised by Ballard [3]): there was
one area of silence, with our exemplar overviews
identifying challenges relating to gaining
agreement with the ROBIS tool. (Note: the ROBIS
tool was published after the search period of
Ballard [3])
o Methodological issue identified by Ballard [3]
but not from our exemplar overviews: there were
two areas of silence. These included challenges
relating to the “scope of systematic reviews”,
where there is a “mismatch” between the scope of
the systematic review and the remit or focus of
the overview, and challenges associated with the
assessment of risk of bias of primary trials, where
appropriate quality assessment was not used
within the systematic review
 Dissonance: there were no areas of dissonance
between the methodological issues raised by our
overviews and Ballard [3]. However, there was
disagreement noted in relation to conclusions drawn
by Ballard [3] relating to the function of overviews
and that overviews cannot identify evidence gaps:
three of our exemplar overviews [19, 21, 23] clearly
concluded that the overview had successfully
identified gaps in the evidence.
Challenges common to systematic reviews
Also common to all exemplar overviews were a number
of challenges which were considered to be routine
amongst most systematic reviews. These included chal-
lenges such as the management of large volumes of re-
view information and data extraction, the available time
and resources, and reaching consensual decisions
amongst overview authors. Strategies implemented to
address these challenges included methods of automat-
ing data extraction (for example downloading data files
for Cochrane reviews) and audio-recording discussions
between overview authors.
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Implications for development of protocols for future
overviews
The identified common methodological features, implica-
tions for future overviews and implications for development
of protocols for future overviews are summarised in Table 4.
Discussion
Using five recently completed or ongoing overviews of re-
views, we have explored the methodological features of
overviews and the key methodological challenges which
are reported by the overview authors and have systematic-
ally compared these findings with synthesised evidence
relating to current guidance for overview methods
(Ballard [3]). Our five overviews provide examples of a
range of different types of overviews, including Cochrane
overviews, mixed method overviews and overviews of
reviews of diagnostic test accuracy. There are some meth-
odological differences between our exemplar overviews
which cannot be attributed to the type or aim of the over-
views, and these arguably occur due to lack of information
and guidance on the optimal methods for overviews and
reinforce recent calls for methodological research and im-
proved guidance for overviews [2, 3, 5, 24, 25].
Eight key methodological challenges were encountered
during our five exemplar overviews; these challenges
were clearly aligned with the areas of debate identified
within current literature [3], with no areas of dissonance.
Areas of silence where a methodological issue was iden-
tified by our exemplar overviews and not by the synthe-
sis by Ballard, and vice versa, can arguably be explained
by differing levels of reporting within these syntheses.
Where there were methods debated within our exemplar
Table 2 Characteristics of included reviews which are reported in tables in overviews
Reported characteristics from included reviews Pollock [19] McClurg [21] Estcourt [20] Hunt [22] Brunton [23]
Review reference √ √ √ √ √
Date of search √ √ √ √
Country (of included studies) √ √ √
Objective of review √ √ √ √
Types of studies included in review √ √ √ √ √
Participants included in review √ √ √ √ √
Intervention included in review (including name or brief description) √ √ √ √
Reference standard(s) included in the review (including details: assessment
tool used, version, assessor details, description)
√
Index test(s) included in review (including brief cognitive assessment
details: name, creator, version, description)
√
Test thresholds included within the review √
Comparisons included in review √ √ √ √
Outcomes included in review √ √ √ √
Target condition being addressed in the review √
Population prevalence of condition addressed in the review √
Setting focus of the review √ √ √
Number of studies included in review √ √ √ √ √
Number of participants included in review √ √ √ √
Other outcomes reported beyond diagnostic test accuracy in the review √
Statistical data from included reviews reported in overview
Effect size √ √ √
Confidence intervals √ √ √ √
2 × 2 table components (TP, FP, TN, FN) √
Sensitivity, specificity √
Positive Predictive Value, Negative Predictive Value √
Tests compared, direct/indirect comparisons √
Heterogeneity (statistical measure) √ √ √ √
Direction of effect √ √ √ √ √
Results of moderator analyses √
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overviews which were not discussed in the synthesis by
Ballard [3], these were always related to a larger topic or
issue for which there was no consensus on an optimal ap-
proach, for example dealing with overlap between reviews.
Our exemplar overviews supported the conclusion that
overviews can successfully identify gaps in the evidence;
this conflicts with Ballard [3] who concludes that over-
views cannot fulfil the function of identifying evidence
gaps. However, Ballard [3] qualifies this, stating that
“overviews that fail to find a systematic review for every
relevant comparison will not, by default, detect evidence
gaps”. Our experiences suggest that there are situations
where evidence gaps will be identified, specifically when
there is documented knowledge of current clinical prac-
tice or existing interventions. For example, during proto-
col development McClurg [21] consulted with a
stakeholder group comprising expert clinicians and pa-
tients, creating a comprehensive list and taxonomy of in-
terventions delivered within clinical practice relevant to
the scope of the overview. While Ballard implies that
overviews cannot fulfil the function of identifying evi-
dence gaps, we argue that this function can be fulfilled,
where there is knowledge of existing interventions or
current clinical practice. This supports the viewpoint
that the involvement of key stakeholders within the
overview process should be an essential component of
overview methodology, serving to increase relevance,
quality and rigor and reduce research waste, as has been
proposed for systematic reviews [26–30].
Our experiences as authors completing overviews, des-
pite an absence of guidance for many methodological
features, and the evidence of the increasing number of
new overviews published each year [1, 2] highlight that
there is a need for recommendations and support for au-
thors wishing to complete overviews during this time of
methodological uncertainty. Clearly, the ultimate goal
must be to address the uncertainties and establish
evidence-based guidance for overview methods, and
there is ongoing work which aims to inform and help
prioritise future research in this field [15]. However,
while there remains a lack of guidance and recommen-
dations for optimal methods, there is currently decision-
making required by the authors of future overviews.
Until sufficient guidance is available, we recommend
that overview authors make and transparently report de-
cisions relating to the inevitable methodological choices.
Based on our experiences as overview authors, we have
proposed a list of implications to be considered during
the development of protocols for future overviews
(Table 4). Whilst we anticipate that these implications
will be superseded by more robust and evidence-based
recommendations as methodological research in this
field is completed, we believe that these offer practical
advice to those embarking on overviews whilst there
remains methodological uncertainty. As this is an active
area of research and the methods for overviews continue
to develop, overview authors should ensure that they re-
main up-to-date with any new guidance or information
on best practice and should take opportunities to build
on the methods of completed overviews. Furthermore,
as the methodological features of overviews are broadly
derived from, and build upon, methods for systematic
reviews of primary research [1, 4, 5], overview authors
should utilise guidance and recommendations relating to
the conduct of systematic reviews [1]. These include the
QUality Of Reporting Of Meta-analyses (QUOROM)
statement [31], Methodological Expectations of
Cochrane Intervention Reviews guidance (MECIR) [32]
and Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines, as well as the
growing body of guidance specific to overviews [1, 4, 33,
34]. As well as ensuring the overview is carried out to the
highest methodological standards, it is essential to ensure
that the overview is relevant and useful, and meaningful
involvement of key stakeholders should be central to all
overviews (Hunt H, Pollock A, Campbell P, Estcourt L,
Brunton G: An introduction to overviews of reviews: plan-
ning a relevant research question and objective for an
overview Systematic Reviews, submitted); resources cur-
rently being developed to support systematic review au-
thors in achieving meaningful stakeholder involvement
[35, 36] ought to be relevant to authors of overviews.
Strengths and limitations
The aim of this paper was to provide illustrated exam-
ples of the methods and challenges associated with a
range of overviews. The objective was not to provide
specific recommendations about how to do an overview,
or to propose optimal methods for overviews. The five
exemplar overviews were initially selected using contacts
for overview authors whom attended a meeting on over-
views at the 2015 Cochrane Colloquium in Vienna. As
the exemplar overviews were initially selected for pres-
entation at the 2016 UK Cochrane meeting, all the se-
lected overviews were led by UK-based authors. Two of
the exemplar overviews include some of the same
authors [19, 21]. Thus, the overviews provided as exam-
ples in this paper are selected from a limited population
of authors and cannot therefore be assumed to be repre-
sentative or comprehensive of the range of different
overviews which have been published internationally.
None of the five exemplar overviews addresses a re-
search question for which there was high quality trial
and review evidence and none of these exemplar over-
views completed network meta-analyses; these are clear
gaps within these example overviews. However, whilst
not purporting to be comprehensive, the examples re-
flect the shared challenges experienced by the authors of
Pollock et al. Systematic Reviews  (2017) 6:145 Page 15 of 18
these five selected overviews, and those which were per-
ceived to be the greatest or most difficult to deal with.
The comparison of the methodological challenges inde-
pendently identified from these exemplar overviews with
the issues emerging from a comprehensive synthesis of
current evidence adds significant strength to this paper,
confirming that the experiences within these exemplar
overviews are aligned with current evidence.
Conclusions
Overviews are a relatively new methodological innovation,
and there are currently substantial variations in the meth-
odological approaches used within different overviews. Fur-
thermore, there are considerable methodological challenges
for which optimal solutions are not necessarily yet known.
This paper has explored the variations in methodological
approaches used within five selected overviews, and the
challenges reported by the overview authors. Lessons learnt
from these overviews have highlighted a number of meth-
odological decisions which may need to be considered dur-
ing the development of an overview protocol and led to the
development of a list of implications to support the devel-
opment of protocols for future overviews (Table 4).
While there remains a lack of empirical evidence to
support selection of specific methodological approaches
[1–3, 5, 6], authors planning protocols for Cochrane
overviews are encouraged to consider and transparently
report their decisions in response to a number of
questions, including the following:
 Is the overview to be limited to Cochrane reviews or
will other systematic reviews also be included?
 Is the search strategy to be limited to databases of
reviews or will wider electronic databases be searched?
 What action will be taken if there are overlapping
reviews (reviews containing the same trials)?
 What action will be taken if included reviews are
out of date? (How will ‘out of date’ be defined?)
 What tool will be used to assess the quality of the
included reviews? (AMSTAR/ROBIS)
 How will the quality of evidence within reviews be
assessed? Will this be done using GRADE (and if so,
how will GRADE be applied to the available evidence)?
 Is any new statistical analysis to be carried out, using
the data extracted from the reviews?
 How will the evidence be brought together into an
accessible summary which is useful to the potential
audience/readership of the overview? What
information should be included within this (in order
to address the overview objective)?
As this is a new and developing methodological field,
it is important that overview authors keep up-to-date
with new developments and methods research, in order
that their decisions relating to the methodological ap-
proach for a new overview are informed by current
evidence.
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